SCHEMBL6710210

SCHEMBL6710210

Cn1c(C(=O)Nc2ccc(C#N)cc2-c2nnn[nH]2)cc2cccc(-c3ccccc3)c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 2/20 0.36
GSK3B P49841 2/20 0.36
KMT2A Q03164 1/20 0.35
CHRM3 P20309 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34
TSHR P16473 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
TRPA1 O75762 1/20 0.34
ROCK1 Q13464 1/20 0.34
CNR2 P34972 1/20 0.34
IDO1 P14902 1/20 0.34
THRB P10828 1/20 0.33
GRM5 P41594 1/20 0.33
F10 P00742 1/20 0.33
KCNA5 P22460 1/20 0.33
PHGDH O43175 1/20 0.33
PRKDC P78527 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710331 0.91 NR1H4 (0.38) KMT2AALDH1A1TP53ROCK1F10
SCHEMBL6708989 0.91 LMNA (0.38) GSK3AGSK3BKMT2ACHRM3TP53
SCHEMBL6710384 0.91 F10 (0.33) ALDH1A1ROCK1F10ATR
SCHEMBL6711902 0.90 THRB (0.37) KMT2AALDH1A1TRPA1THRBF10
SCHEMBL6710104 0.89 TRPA1 (0.33) KMT2ATRPA1THRBGRM5
SCHEMBL6712448 0.89 KDM4E (0.36) GSK3AGSK3BALDH1A1HSD17B10
SCHEMBL6713833 0.88 CXCR1 (0.34) GSK3AGSK3BKMT2ANPSR1TRPA1
SCHEMBL6707965 0.88 NTRK1 (0.35) KMT2ATRPA1THRB
SCHEMBL6709087 0.88 TRPA1 (0.42) KMT2ATP53TRPA1ROCK1
SCHEMBL6710144 0.87 ROCK1 (0.39) KMT2ACHRM3ALDH1A1NPSR1ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GSK3A 4158/4885GSK3B 4467/4885KMT2A 3181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.